Potential new targets for treating pain in women have been identified by researchers, which could lead to treatments to help those who are uncomfortable due to spinal injury.
Chronic pain is experienced very differently by men and women, researchers noted, but as opiate receptors are not believed to differ dramatically between the sexes, it was not understood why.
Research published in the Journal of Neuroscience found that the same major types of opioid receptor interact differently in men and women.
Dr Alan Gintzler, study leader, said: "This consideration could become even more critical in managing pain in postmenopausal and elderly women.
"Further research is needed to flesh out these possibilities."
Meanwhile, research published in the Journal of Biological Chemistry has revealed that the CDB3 peptide is able to help those with chronic pain, as it short circuits the pathway without interfering with other nerve functions.
While it was previously thought the peptide would trigger the death of brain cells, the research showed that it could actually be used to prevent cell death following a traumatic brain injury.
News by Serious Law. Expert legal assistance for those affected by spinal injury
Posted by Paul Breen
